 TopNews United States | Cell Therapeutics drug draws US FDA staff concerns Reuters WASHINGTON, Feb 8 (Reuters) - US drug reviewers questioned effectiveness data from Cell Therapeutics Inc (CTIC.O) (CTIC.MI) for an experimental lymphoma drug and said the medicine had substantial side effects, according to documents ... US Drug Reviewers Rebukes Cell Therapeutics Drug TopNews United States Abridged Study to Haunt CTI? FDA Questions Pixantrone Data BioWorld Online FDA Postpones Panel Meeting To Review Cell Therapeutics' Drug Due To Extreme ... RTT News MarketWatch - TheStreet.com - Forbes (blog) all 82 news articles » |
Cell Therapeutics drug draws US FDA staff concerns – Reuters
Previous post: Twins learn of teen brother’s death on Facebook
Next post: Virtualizing a Supercomputer
Comments on this entry are closed.